Pura Vida Investments’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Pura Vida Investments’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,214	Closed	-$956K	–	96
2017 Q1	$956K	Buy	+3,214	New	+$811K	0.28%	62
2016 Q4	–	Sell	-3,643	Closed	-$875K	–	99
2016 Q3	$875K	Buy	3,643 +1,422	+64%	+$296K	0.27%	73
2016 Q2	$435K	Buy	2,221 +1,071	+93%	+$494K	0.18%	68
2016 Q1	$493K	Hold	1,150	–	–	0.22%	69
2015 Q4	$435K	Hold	1,150	–	–	0.18%	66
2015 Q3	$312K	Hold	1,150	–	–	0.18%	60
2015 Q2	$337K	Hold	1,150	–	–	0.17%	63
2015 Q1	$317K	Buy	+1,150	New	+$497K	0.16%	60

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

LCM

Leisure Capital Management Costa Mesa, California $320M AUM 39.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

SGS

Sterling Global Strategies Carlsbad, California $18M AUM 11.58% 1-Year Est. Return

Pura Vida Investments's DMK Position: Q2 2017 in Review

Pura Vida Investments sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2017, closing a stake of 3,214 shares — an estimated $956K sold.

Pura Vida Investments first reported a position in DMK in Q1 2015 and held it in 8 quarters. The position peaked at $956K in Q1 2017. 44 funds tracked by Wall St. Rank hold DMK as of Q2 2017.

Pura Vida Investments reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2017 after selling out during the quarter.
Pura Vida Investments sold 3,214 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2017, an estimated $956K.
Pura Vida Investments first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2015 and held it in 8 quarters.
Pura Vida Investments's DMK Pharmaceuticals Corporation Common Stock position peaked at $956K in Q1 2017.
44 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2017.

Based on Pura Vida Investments's 13F filing for Q2 2017, filed 14 Aug 2017.